Calendar of CURE/Yale BioHaven seminars for Fall 2010 now available. more
9/14
8:45 am - 6:00 pm

Ubifrance, the French Agency for international business development, cordially invites CURE members to this year's second French Biotech Tour, which aims to connect French and American Biotech companies specialized in neuroscience, inflammation, and auto-immune diseases. Philadelphia, PA. more
9/16
6:00 pm - 7:30 pm

CURE/Yale BioHaven presents Al Mann: 'Creating a successful medical device enterprise.' Hope Auditorium, Yale University, 315 Cedar Street, New Haven. more
10/5
Deadline for nominations for the Lemelson-MIT prize, awarded to an outstanding mid-career inventor who has developed a patented product or process of significant value to society. more
10/14
4:00 pm - 7:00 pm

Hartford Hospital Research Symposium. 'Personalized Medicine and Genomics: The Future is Now.' RSVP by 10/1 to 860.545.5620. Heublein Hall, Education & Resource Center, Hartford Hospital, Hudson Street, Hartford. more
10/27
4:00 pm - 6:00 pm

CURE/Yale BioHaven presents Cobalt Therapeutics. Anlyan Center, Yale University, 300 Cedar Street, New Haven. more
11/18
4:00 pm - 6:00 pm

CURE/Yale BioHaven presents Biodel Inc. Anlyan Center, Yale University, 300 Cedar Street, New Haven. more
12/7
5:30 pm - 7:30 pm

CURE Holiday Party. Café George, 300 George Street, New Haven. Watch for details.


Johnson & Johnson
410 George Street
New Brunswick, NJ 08901

Phone: 908-524-0400
Website: http://www.jnj.com

Contact(s)
Sheldon Sloan

General Information
Johnson & Johnson is the world's largest and most comprehensive manufacturer of health care products serving consumer, pharmaceutical and professional markets.



Since the Company's founding in 1886, Johnson & Johnson continues to provide innovative health care products that improve or save lives. A shared system of values, known as Our Credo, serves as a guide for all who are part of the Johnson & Johnson Family of Companies.



Our worldwide Environmental Commitment demonstrates how we live up to our Credo responsibility to protect our natural resources. And our Corporate Contributions program serves as a lifeline for Social Responsibility initiatives in communities in which we live and work around the world.

Other Information
Ownership: Public
Stock Symbol: JNJ
Total Sales Revenue: $21.6 Billion - '96

Back